Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients

NCT04559334 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT04559334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04559334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients
Lead sponsor
Boston Children's Hospital
Phase
Not applicable
Overall status
Suspended
Start date
December 21, 2020
Completion date
December 31, 2027
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central line complication, central line-associated bloodstream infection (clabsi)